Impact of thoracic multidisciplinary tumor boards on the management of patients with cancer: A retrospective study at the American university of Beirut medical center

被引:1
|
作者
Kreidieh, Firas [1 ]
Tfayli, Arafat [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, 1755 Wyndale St, Houston, TX 77030 USA
[2] Amer Univ Beirut, Div Hematol Oncol, Med Ctr, Beirut 11072020, Lebanon
关键词
tumor boards; lung cancer; multidisciplinary; efficacy; LUNG; RECOMMENDATIONS;
D O I
10.3892/mco.2022.2602
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multidisciplinary tumor boards (MDT) provide an opportunity for experts from different specialties and expertise to pool and complement each other's experience and inputs. Several factors impact the MDT discussions, including the meeting's structure, time management, and expert leadership. The process of MDT, their utilization, and efficacy need continuous assessment and improvement. A retrospective study was conducted to review the process of thoracic MDT, their plans of therapy, and changes in diagnosis and treatment plans for patients with cancer at the American University of Beirut Medical Center (AUBMC) over the period of one year. The primary outcome measure was the percentage of patients presented at the thoracic MDT who had a change in their treatment plan after the presentation. A total of 214 cases were scheduled for thoracic MDT during the study period. The majority, 132 (61.7%) did not have a treatment plan before presenting in the MDT. Of the 195 cases presented, only 43 (22.0%) did not have a change in their plan, while 88 (45.2%) of the cases presented had a change in their treatment plan. A total of 64 (32.8%) cases consisted of discussion of the diagnosis during MDT with either confirmation or modification of the patients' diagnosis. Of the 195 cases that were presented, the majority, 170 (87.2%), had their recommended treatment plan implemented after the MDT discussion. There was an association between the stage of cancer at the time of presentation and requesting additional tests (P=0.021), but there was no association between the stage of cancer and change in treatment plan (P=0.177) nor with implementation of recommendation (P=0.217). MDT are used to make upfront management decisions. In addition to considering change in management plans as an indicator of the benefit of MDT, it is suggested that making upfront multidisciplinary plans shall be considered an additional component of indicators of the benefit of MDT.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Incidence of Cytomegalovirus (CMV) Reactivation after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in 324 Patients with Multiple Myeloma and Lymphoma: A Single-Center Study at the American University of Beirut Medical Center (AUBMC)
    Massoud, Radwan
    Assi, Rita
    Fares, Elie
    Kreidieh, Nabila
    Mahfouz, Rami
    Kanj, Souha
    El-Zakhem, Aline
    Kharfan-Dabaja, Mohamed A.
    Bazarbachi, Ali
    El Cheikh, Jean
    [J]. BLOOD, 2016, 128 (22)
  • [42] Thoracic Multidisciplinary Tumor Board Routinely Impacts Therapeutic Plans in Patients With Lung and Esophageal Cancer: A Prospective Cohort Study
    Schmidt, Henner M.
    Roberts, John M.
    Bodnar, Artur M.
    Kunz, Sonia
    Kirtland, Steven H.
    Koehler, Richard P.
    Hubka, Michal
    Low, Donald E.
    [J]. ANNALS OF THORACIC SURGERY, 2015, 99 (05): : 1719 - 1724
  • [43] The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer
    Lowes, Markus
    Kleiss, Mathias
    Lueck, Rainer
    Detken, Sven
    Koenig, Alexander
    Nietert, Manuel
    Beissbarth, Tim
    Stanek, Kathrin
    Langer, Claus
    Ghadimi, Michael
    Conradi, Lena-Christin
    Homayounfar, Kia
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (10) : 1463 - 1469
  • [44] The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer
    Markus Lowes
    Mathias Kleiss
    Rainer Lueck
    Sven Detken
    Alexander Koenig
    Manuel Nietert
    Tim Beissbarth
    Kathrin Stanek
    Claus Langer
    Michael Ghadimi
    Lena-Christin Conradi
    Kia Homayounfar
    [J]. International Journal of Colorectal Disease, 2017, 32 : 1463 - 1469
  • [45] PROSPECTIVE STUDY OF THE CLINICAL AND SEROLOGICAL CHARACTERISTICS AND LONG-TERM EVOLUTION OF THE ANTI PHOSPHOLIPID SYNDROME AT THE AMERICAN UNIVERSITY OF BEIRUT MEDICAL CENTER. THE LEBANESE ANTIPHOSPHOLIPID SYNDROME STUDY GROUP
    Uthman, I. U.
    Bazzi, L. B.
    Taher, A. T.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 421 - 421
  • [46] Second-line Modified GTX versus Gemcitabine- Nab-Paclitaxel (GmAb) Following First-Line FOLFIRINOX in Advanced Pancreatic Cancer: A Retrospective Analysis at the American University of Beirut Medical Center (AUBMC)
    Temraz, Sally
    Kreidieh, Firas
    Nassar, Farah
    Mezher, Maria
    Mukherji, Deborah
    Shamseddine, Ali
    [J]. MIDDLE EAST JOURNAL OF CANCER, 2023, 14 (04) : 550 - 558
  • [47] Retrospective study evaluating the impact of genomic profiling on management of patients with metastatic breast cancer
    Amin, A. A.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [48] Treatment Outcomes and Associated Factors in Tuberculosis Patients at Jimma University Medical Center: A 5-Year Retrospective Study
    Abebe, Gemeda
    Bonsa, Zegeye
    Kebede, Wakjira
    [J]. INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2019, 8 (01) : 35 - 41
  • [49] Examining the Use of Oral Aripiprazole in Patients With Autism Spectrum Disorder: A Study of Retrospective Chart Review at a University Medical Center
    Han, Jae Hyun
    Kim, Jong Myeong
    Yoo, Hee Jeong
    [J]. JOURNAL OF THE KOREAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2024, 35 (02): : 136 - 142
  • [50] Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study
    Taro Shibuki
    Mitsuhito Sasaki
    Shota Yamaguchi
    Kanae Inoue
    Tomonao Taira
    Tomoyuki Satake
    Kazuo Watanabe
    Hiroshi Imaoka
    Shuichi Mitsunaga
    Takeshi Fujisawa
    Kento Tomizawa
    Hidekazu Oyoshi
    Masaki Nakamura
    Hidehiro Hojo
    Masafumi Ikeda
    [J]. Radiation Oncology, 18